Navigation Links
AquaStar Holdings, Inc. Subsidiary Appoints Former Beckman Coulter Executive as Vice President of Operations
Date:6/3/2011

SANTA ANA, Calif., June 3, 2011 /PRNewswire/ -- AquaStar Holdings, Inc. (Pink Sheets: RPPR) is pleased to announce that the Company's wholly-owned subsidiary, SUTIMCo, Inc., has retained the services of Mr. Ed Ellsworth as Vice President of Business Development.  Mr. Ellsworth will assist with the development and positioning of the numerous University conceived technologies that SUTIMCo manages. Mr. Ellsworth, who comes to SUTIMCo straight from Beckman Coulter (NYSE: BEC), will be immediately tasked with the development of the Capwave Enzyme-Linked Immuno-Sorbent Assay (ELISA) platform technology.

Mr. Ellsworth brings more than 20 years experience in the diagnostic and life science industry with a focus on commercializing and advancing technology across the life science continuum. Mr. Ellsworth has numerous years with Beckman Coulter, a leader in the Biotechnology Industry with over $3.7 billion in revenue for 2010, where most recently he was responsible for operational marketing and business management of the immunochemistry, hematology, chemistry and rapid diagnostic testing products for the channel business. In addition, Mr. Ellsworth directed the distributor partnership corporate accounts group delivering over $100 million in revenue.

"SUTIMCo is in the forefront of bringing exciting new technologies to market.  I'm delighted to be on the team and I look forward to working with SUTIMCo management," stated Ed Ellsworth, Vice President of Business Development of SUTIMCo, Inc.

"Ed's appointment further deepens our understanding of the diagnostic and life science industry and will be a tremendous contribution as we develop our client companies," stated Malcolm Lennie, President of AquaStar Holdings, Inc. "He comes with extensive, real-life understanding of technology commercialization that will be a valuable asset to the Company."

For more information on SUTIMCo, its portfolio companies, and University partners, please visit; http://www.suti.com

About AquaStar Holdings, Inc.:

AquaStar Holdings, Inc. is a holding company, which utilizes a unique and established platform to launch new technology enterprises based on world-class university research discoveries. AquaStar Holdings, through its wholly owned subsidiary SUTIMCo, Inc., provides experienced management to early stage companies, reducing risk and assuring the know-how in launching and growing a new company. In addition to this skilled management team, AquaStar Holdings can avail itself of the encyclopedic, informal knowledge of the inventor, his experience and his research team.

Safe Harbor: Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, technology efficacy and all other forward-looking statements be subject to the safe harbors created thereby. The Company is a development stage company who continues to be dependent upon outside capital to sustain its existence. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results

Investor Relations
407-389-5900


'/>"/>
SOURCE AquaStar Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. AquaStar Holdings, Inc.s Client Receives U.S. Patent 7,708,944 for Portable Capillary Sensor Technology
2. China Pharma Holdings, Inc. Will Attend the Susquehanna Financial Group, LLP (SIG) Beijing Management Summit
3. Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology
4. China Pharma Holdings, Inc. Projects 3rd Quarter 2008 Revenue Growth to Exceed 40%
5. China Pharma Holdings, Inc. Appoints The Ruth Group
6. BioAuthorize Holdings, Inc. Names New Directors and Executive and Unveils Modification to Its Voice Biometric Authentication Service
7. China Pharma Holdings, Inc. to Present at Two Upcoming U.S. Investor Conferences
8. China Pharma Holdings, Inc. Receives SFDA Production Approval for Tiopronin Enteric-Coated Capsules
9. China Pharma Holdings, Inc. Announces Clinical Trials Already Underway for Candesartan
10. JAG Media Holdings, Inc. Announces Letter of Intent for the Acquisition of CardioGenics Inc. by a Wholly-Owned Subsidiary of JAG Media
11. EFT BioTech Holdings, Inc.s Subsidiary Receives First Permit to Cross Taiwan Strait
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... 09, 2016 , ... DuPont Industrial Biosciences (DuPont) and Archer ... Year Award from Platts Global Energy for their platform technology to produce ... at the 18th Platts Global Energy Awards, held in New York on Thursday, Dec. ...
(Date:12/9/2016)... 2016 The research report by ... in the  Global Label-Free Array Systems Market  accounted for ... 2015. Players such as Biacore, Agilent Technologies, ForteBio, Molecular ... the global market due to their unmatched product portfolio ... upgrades and timely product launches are expected to be ...
(Date:12/9/2016)... 2016 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic ... the results of its 2016 Annual General Meeting, which was ... China . At the Annual ... of KPMG Huazhen LLP as the independent auditors of the ...
(Date:12/9/2016)... According to a new market research report ... Reagent Equipment), Application (Research, PCR, Gene, DNA, NGS, Diagnostic, RNAI), End ... the global market is expected to reach USD 2.20 Billion by ... 10.6% during the forecast period. Continue ... ...
Breaking Biology Technology:
(Date:11/22/2016)... 22, 2016   MedNet Solutions , an innovative ... of clinical research, is pleased to announce that the ... and Life Sciences Awards as "Most Outstanding in ... unprecedented year of recognition and growth for MedNet, which ... years. iMedNet ™ , MedNet,s ...
(Date:11/17/2016)... 17, 2016 Global Market Watch: Primarily ... Banks, Population-Based Banks and Academics) market is to witness a ... Biobanks shows the highest Compounded Annual Growth Rate (CAGR) of ... during the analysis period 2014-2020. North America ... followed by Europe at 9.56% respectively. ...
(Date:11/15/2016)... Nov. 15, 2016  Synthetic Biologics, Inc. (NYSE ... focused on the gut microbiome, today announced the ... shares of its common stock and warrants to ... a price to the public of $1.00 per ... Biologics from the offering, excluding the proceeds, if ...
Breaking Biology News(10 mins):